Key result
ILR placements rise to ~4.1 per 100,000 patient-days, driven by growth in non-guideline indications.
Why the study?
Professional society guidelines recommend ILR use for recurrent syncope and cryptogenic stroke, but recommendations are weaker for other indications and ILR use patterns over time are unclear.
Cohort (n=47,046,706)
Yes
ILR placements are increasing, particularly for indications not addressed by current guidelines, and often occur without prior long-term rhythm monitoring.
Background: Implantable loop recorders (ILRs) provide continuous rhythm monitoring. Professional society guidelines and expert consensus statements recommend ILR use for patients with recurrent syncope and cryptogenic stroke, but recommendations are weaker for other indications. We assessed ILR use over time and concordance between indication and clinical guidance. Methods: We conducted a retrospective cohort study using Epic Cosmos data from 1/1/2020-12/31/2025. Among active patients with at least one of 13 diagnoses potentially eligible for ILR placement, we identified ILR placements and classified them by concordance with professional society guidance: concordant, possibly, or non-addressed. Annual incidence was estimated overall and by indication. We also described the proportion of patients who received longer-term (>7 days) rhythm monitoring in the year prior to placement. Results: Of 47,046,706 patients with diagnoses potentially eligible for ILR placement, 201,103 (0.4%) had an ILR placed. ILR placements increased from 3.08 ILRs per 100,000 patient-days in 2020 to 4.13 in 2025 (5.9% annual growth). The most common indications were cryptogenic stroke (28.6%) and atrial fibrillation without prior ablation (21.4%). Overall, 43.9% were guidance concordant, 28.5% possibly concordant, and 24.8% non-addressed. Relative annual growth in ILR placements per 100,000 patient-days was significant across all guidance categories: concordant (1.3%, 95% CI, 0.9%-1.7%), possibly concordant (5.5%, 95% CI, 5.0%-6.0%) and non-addressed (7.4%, 95% CI, 6.8%-8.0%). Among 125,631 outpatient placements, 50,181 (39.9%) had any prior long-term rhythm monitoring. Conclusion: ILR placements are uncommon but increasing, with faster annual growth for indications that may not be guidance concordant. More than half of patients lacked long-term rhythm monitoring prior to outpatient ILR placement. What is known: Prior research through 2018 demonstrated that many ILRs were placed for indications not supported by professional society guidelines or expert consensus statements.Implantable loop recorder (ILR) technology has advanced with longer battery life, easier implantation processes, and robust remote monitoring and reprogramming. What the Study Adds: ILR use remains uncommon for patients with diagnoses potentially eligible for ILR placement.Annual incidence of ILR placement is increasing, especially among patients with indications not addressed by professional society guidelines or expert consensus statements.Most ILR placements occur without pre-implant rhythm monitoring.
No takes yet. Share an insight, caveat, or question.
Andersen et al. (2026) conducted a cohort in Conditions potentially eligible for implantable loop recorder placement (n=47,046,706). Implantable loop recorder placement was evaluated on Annual incidence of ILR placement and concordance with clinical guidance. Implantable loop recorder placements increased from 3.08 to 4.13 per 100,000 patient-days (2020-2025), with fastest growth in non-addressed indications (7.4% annual growth; 95% CI 6.8%-8.0%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: